N-(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)-3-HYDROXY-4-(2-(2-METHOXY-4-NITROPHENYL)DIAZENYL)-2-NAPHTHALENECARBOXAMIDE
UNII HM2QQL7LGE
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxy-4-(2-(2-methoxy-4-nitrophenyl)diazenyl)-2-naphthalenecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HM2QQL7LGE.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 6985-95-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H18N6O6 HECMZBWRWWVBJI-QVIHXGFCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxy-4-(2-(2-methoxy-4-nitrophenyl)diazenyl)-2-naphthalenecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.